Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
7,180,472
-
Shares change
-
+7,076,001
-
Total reported value, excl. options
-
$199,536,396
-
Value change
-
+$197,487,337
-
Number of buys
-
49
-
Number of sells
-
-3
-
Price
-
$27.79
Significant Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2014
53 filings reported holding AKBA - Akebia Therapeutics, Inc. - Common Stock as of Q2 2014.
Akebia Therapeutics, Inc. - Common Stock (AKBA) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,180,472 shares
of 236,234,693 outstanding shares and own 3.04% of the company stock.
Largest 10 shareholders include Novo A/S (1,516,387 shares), FMR LLC (1,019,100 shares), HealthCor Management, L.P. (900,000 shares), RA CAPITAL MANAGEMENT, LLC (597,363 shares), FRANKLIN RESOURCES INC (510,400 shares), STIFEL FINANCIAL CORP (444,904 shares), Cormorant Asset Management, LLC (400,000 shares), MORGAN STANLEY (396,849 shares), BlackRock Fund Advisors (192,817 shares), and JENNISON ASSOCIATES LLC (178,975 shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.